vimarsana.com

Page 6 - ஸ்பானிஷ் தேசிய புற்றுநோய் ஆராய்ச்சி மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Heart disease drug reverses obesity in mice by targeting inflammation

Heart disease drug reverses obesity in mice by targeting inflammation Heart disease drug reverses ob. Fat cells might have a new foe, in the form of an already available heart disease drug that new research shows can reverse obesity in mice 1/2 Fat cells might have a new foe, in the form of an already available heart disease drug that new research shows can reverse obesity in mice 2/2 Fat cells in an obese mouse (left) and a mouse treated with digoxin (right), where improved fat burning can be observed CNIO Researchers are continuing to unravel the complex relationship between inflammation and obesity, and through a new study involving overweight mice and a repurposed heart disease drug, a group of scientists in Spain has uncovered new evidence of how the two are closely connected. The obese rodents treated with the medication experienced a 40-percent weight loss even while continuing with their unhealthy diets, and were also cured of

This existing heart drug could help treat obesity

This existing heart drug could help treat obesity Credit: CC0 Public Domain It has long been known that obesity is an inflammatory disease, i.e. a chronic defensive reaction of the body to stress caused by excess nutrients. In a new study from Spanish National Cancer Research Centre, researchers found that digoxin, a drug already in use against heart diseases, could reduce inflammation and leads to a 40% weight loss without any side effects. Digoxin reduces the production of a molecule called interleukin 17A, or IL-17A, which generally triggers inflammation. The study identifies IL-17A as a causal factor of obesity.

CNIO researchers discover that a drug already in use in humans corrects obesity in mice

 E-Mail IMAGE: Visualization of adipocytes from an obese mouse (left) and from a lean mouse treated with digoxin (right), showing a better response to nutrient excess and burning of fat. view more  Credit: CNIO It has long been known that obesity is an inflammatory disease, i.e. a chronic defensive reaction of the body to stress caused by excess nutrients. Based on this knowledge, a group of researchers led by Nabil Djouder, head of the Growth Factors, Nutrients and Cancer Group at the Spanish National Cancer Research Centre (CNIO), decided to try to fight obesity by preventing inflammation - and they succeeded. Their paper, published this week in

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.